IPH addresses FY25 earnings variance, sets AGM date

IPH Limited confirmed that its FY25 Underlying EBITDA of $207.2 million was 1.4% below consensus, and Underlying NPATA of $120.6 million was 4.1% below consensus. Both figures remained within the 15% materiality threshold referenced by ASX Guidance Note 8. Statutory NPAT of $68.8 million was 12.2% below consensus. The company stated it does not consider these variances materially different from market expectations, as its key metrics remained well within guidance. IPH used a consensus estimate methodology, based on 9 sell-side analysts, with data last compiled on July 17, 2025.

The company attributed the post-announcement share price decline to several factors, including continued weakness in Patent Cooperation Treaty filings from the US, delays in trading recovery in Canada due to CIPO system issues, and a slower conversion rate of increased patent filings in Asia to revenue in FY25. The IPH Board confirmed its compliance with Listing Rule 3.1.

IPH also announced its Annual General Meeting will be held on Thursday, November 20, 2025, at 10:30 am (AEDT). The closing date for director nominations is Thursday, October 2, 2025, with the Notice of AGM available by Tuesday, October 21, 2025. Additionally, changes in director interests were noted for Andrew Nathaniel Blattman, who acquired 92,788 fully paid ordinary shares on August 27, 2025, increasing his direct holdings to 397,366 shares, and disposed of 259,481 performance rights. David Stoddart Wiadrowski acquired 10,000 fully paid ordinary shares for $48,000 and another 10,000 for $45,800 on August 27 and 28, 2025, respectively, bringing his total indirect holdings to 32,000 shares.